Clinical trials
Phase 1/2 Uterine Cervical Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2013 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| All India Institute of Medical Sciences | 1 |
| Innolake Biopharm | 1 |
| Julius-Maximilians University | 1 |
| NGM Biopharmaceuticals, Inc | 1 |
| Peking Union Medical College Hospital | 1 |
| Peking University Third Hospital | 1 |
| Shanghai Huaota Biopharmaceutical Co., Ltd. | 1 |
| Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 8 |
| Melanoma | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Ovarian Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Cholangiocarcinoma | 1 |
| Colonic Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.